Sugi Predict

Sugi Predict / Compounds / SCHEMBL4395035

SCHEMBL4395035

SCHEMBL4395035

COc1ccc2c(c1)C(=O)C(O)(O)C2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 10/20 1.00
▸ CA2 P00918 10/20 1.00
▸ CA7 P43166 10/20 1.00
▸ CA9 Q16790 10/20 1.00
▸ CA4 P22748 3/20 1.00
▸ MEN1 O00255 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ GAA P10253 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.48
▸ TSHR P16473 1/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ CASP1 P29466 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ BACE1 P56817 1/20 0.48
▸ EHMT2 Q96KQ7 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MAPT P10636 2/20 0.47
▸ APP P05067 1/20 0.47
▸ SNCA P37840 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL1222259 0.98 CA1 (0.96) CA1CA2CA7CA9CA4
SCHEMBL11137560 0.89 CA1 (0.79) CA1CA2CA7CA9CA4
SCHEMBL25835264 0.76 CA1 (0.61) CA1CA2CA7CA9CA4
SCHEMBL25835261 0.76 CA1 (0.61) CA1CA2CA7CA9CA4
SCHEMBL8856863 0.76 CA1 (0.60) CA1CA2CA7CA9CA4
SCHEMBL7984798 0.75 CA1 (1.00) CA1CA2CA7CA9CA4
SCHEMBL8856855 0.75 CA1 (0.59) CA1CA2CA7CA9CA4
SCHEMBL25837698 0.75 CA1 (0.59) CA1CA2CA7CA9CA4
SCHEMBL25837688 0.75 CA1 (0.59) CA1CA2CA7CA9CA4
SCHEMBL25836419 0.75 CA1 (0.59) CA1CA2CA7CA9CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2230287-B1 PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME LG CHEMICAL LTD (KR) 2013-06-12 — — EP claimed
US-20080248583-A1 Quantitative and Qualitative Chelation Measuring Methods and Materials ALBION LABORATORIES, INC. (US) 2008-10-09 — — US claimed
WO-2006034195-A2 QUANTITATIVE AND QUALITATIVE CHELATION MEASURING METHODS AND MATERIALS ALBION LABORATORIES, INC. (US) 2006-03-30 — — WO claimed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 — — US claimed
CN-119619121-A Sweat-like liquid and application thereof in preparation of artificial fingerprints 四川警察学院 2025-03-14 — — CN disclosed
EP-2722042-B1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES KOREA RES INST CHEMICAL TECH (KR) 2019-05-29 — — EP disclosed
US-9890133-B2 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R&D (BE) 2018-02-13 — — US disclosed
US-20160297789-A1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2016-10-13 — — US disclosed
US-9464067-B2 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) 2016-10-11 — — US disclosed
US-20140114068-A1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) 2014-04-24 — — US disclosed
EP-2722042-A2 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES Korea Research Institute of Chemical Technology (KR) 2014-04-23 — — EP disclosed
US-8272343-B1 Fingerprint goggles WEAVER DAVID E (US) 2012-09-25 — — US disclosed
US-20080248583-A1 Quantitative and Qualitative Chelation Measuring Methods and Materials ALBION LABORATORIES, INC. (US) 2008-10-09 — — US disclosed
US-7182791-B2 Composition and method of dyeing keratin fibers comprising at least one heteroalkyl group comprising at least one ninhydrin derivative L'OREAL S.A. (FR) 2007-02-27 — — US disclosed
WO-2006034195-A2 QUANTITATIVE AND QUALITATIVE CHELATION MEASURING METHODS AND MATERIALS ALBION LABORATORIES, INC. (US) 2006-03-30 — — WO disclosed
EP-1537851-A1 Use of ninhydrin derivatives in colouring L'OREAL (FR) 2005-06-08 — — EP disclosed
US-20050060818-A1 Composition and method of dyeing keratin fibers comprising at least one heteroalkyl group comprising at least one ninhydrin derivative L'OREAL S.A. (FR) 2005-03-24 — — US disclosed
US-20030035917-A1 Image making medium HYMAN SYDNEY (US) 2003-02-20 — — US disclosed
US-6485981-B1 Method and apparatus for imaging and documenting fingerprints CIENCIA, INC. 2002-11-26 — — US disclosed
US-5591848-A Spiroconjugated charge-transfer dyes for optical applications THE PENN STATE RESEARCH FOUNDATION (US) 1997-01-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297789-A1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES RNASE1, IAPP, TESK1 CA1 2725/4885CA2 3443/4885CA7 2412/4885
US-20140114068-A1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES RNASE1, IAPP, FOXK1 CA1 2694/4885CA2 3617/4885CA7 2847/4885
US-20050060818-A1 Composition and method of dyeing keratin fibers comprising at least one heteroalkyl group comprising at least one ninhydrin derivative KRT18, C9, S100A6 CA1 96/4885CA2 913/4885CA7 291/4885
US-20080248583-A1 Quantitative and Qualitative Chelation Measuring Methods and Materials AAAS, LIG4, HAMP CA1 1739/4885CA2 2737/4885CA7 2509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.